Intervacc is trading at €0.05 (-6.83%) today, tracking a broader market downturn and sector-wide weakness in biotechnology.
- The decline coincided with a global risk-off session, marked by a significant sell-off in U.S. technology and AI-related stocks.
- Biotech sector pressure provided additional headwinds, with the XBI index reported down 3% during the November 5 market update.
- No new company-specific catalysts were found to account for the move, suggesting the price action is driven by external market and sector factors.